[Molecular targeting therapy for treatment of non-small-cell lung carcinoma].
Okamoto
Isamu
I
Dept. of Medical Oncology, Kinki University School of Medicine, Osaka, Japan.
D000818:Animals; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use; D002289:Carcinoma, Non-Small-Cell Lung / Q000276:immunology / Q000378:metabolism* / Q000628:therapy*; D066246:ErbB Receptors / Q000037:antagonists & inhibitors / Q000276:immunology / Q000378:metabolism; D006801:Humans; D007167:Immunotherapy / Q000009:adverse effects; D015398:Signal Transduction / Q000187:drug effects; D042461:Vascular Endothelial Growth Factor A / Q000378:metabolism
D042461:Vascular Endothelial Growth Factor A; D066246:ErbB Receptors